Earnings Call Insights: Pediatrix Medical Group (MD) Q4 2025 Management View Mark Ordan, Chief Executive Officer, highlighted strong Q4 results with adjusted EBITDA of $66 million, consistent with upwardly adjusted guidance, and cited strong volume, acuity, and payer mix as key factors. Ordan stated, “Throughout 2025, including the fourth quarter, strong volume, acuity and payer mix, combined with...
Earnings Call Insights: Pediatrix Medical Group (MD) Q4 2025 Management View Mark Ordan, Chief Executive Officer, highlighted strong Q4 results with adjusted EBITDA of $66 million, consistent with upwardly adjusted guidance, and cited strong volume, acuity, and payer mix as key factors. Ordan stated, “Throughout 2025, including the fourth quarter, strong volume, acuity and payer mix, combined with strong financial control, gave rise to these results.” He announced the introduction of two new programs to further align physicians with the company: a bonus program tied to stock price performance and the launch of Pediatrix Partners, a leadership group of 46 physicians receiving stock price tracking grants, aiming to strengthen organizational cohesion and clinical leadership. Ordan projected 2026 adjusted EBITDA in the range of $280 million to $300 million, noting, “We expect our results in 2026 to be in the range of $280 million to $300 million, which at its midpoint, of course, is 5% above 2025.” He emphasized operational initiatives expected to favorably impact adjusted EBITDA and reaffirmed commitment to exploring telemedicine and growth within core specialties including NICUs and maternal-fetal medicine. Kasandra Rossi, Executive VP, Treasurer & CFO, reported that consolidated revenue was affected by net non-same-unit activity of $26 million, largely due to portfolio restructuring, though partially offset by acquisition and organic growth. Rossi explained, “This decrease was partially offset by same-unit growth of 4%, with same-unit pricing up just under 7% and overall patient service volumes down just under 3%.” Outlook Management projected full-year 2026 revenue of approximately $1.9 billion, in line with 2025. Rossi indicated that this outlook is based on the assumption of “flat both in volume and in pricing,” expecting metrics to remain consistent with 2025. Full-year G&A expense is anticipated in the $230 million to $240 million range, compared to $241 million...